Projects funded by the NCN
CD200R signaling in infmallation and immune cancer responses: a tricky balance
2011/03/D/NZ6/03685
Keywords:
CD200 CD200R inflammation tumor-induced inflammation anti-tumor response cancer immuno-therapy mice experimental modles
Descriptors:
- NZ6_1: Adaptive and innate immunity
- NZ6_2: Clinical immunology
- NZ6_8: Other related subjects
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Warszawski Uniwersytet Medyczny, I Wydział Lekarski
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: SONATA 2 - announced on 2011-09-15
Amount awarded: 998 100 PLN
Project start date (Y-m-d): 2012-09-17
Project end date (Y-m-d): 2016-09-16
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Equipment purchased [PL]
- homogenizatora tkankowego (Gentle MACS) (23 000 PLN)
- komora laminarna (16 000 PLN)
- wytrząsarka typu Vortex.
- inkubator do hodowli (27 000 PLN)
- kołyska laboratoryjna.
Information in the final report
- Publication in academic press/journals (1)
- The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodiesAuthors:Pilch Z, Tonecka K, Skorzynski M, Sas Z, Braniewska A, Kryczka T, Boon L, Golab J, Meyaard L, Rygiel TPAcademic press:PLoS One (rok: 2019, tom: 14, strony: 45302), Wydawca: Public Library of ScienceStatus:PublishedDOI:10.1371/journal.pone.0210796 - link to the publication